MFCEM Dialogues #15
by
Dr Sahil Bajaj,
Cancer Systems Imaging, Division of Diagnostics Imaging, The University of Texas MD Anderson Cancer Center
on
From Brain Mapping to Precision Health: AI and Neuroimaging Across Health and Disease
July 16, 2026
Dr. Sahil Bajaj is an assistant professor in the department of Cancer Systems Imaging at the University of Texas MD Anderson Cancer Centre in Houston; prior to which he was a research scientist and director of the Multimodal Clinical Neuroimaging Laboratory at Boys Town National Research Hospital, Nebraska. Dr Bajaj has received numerous awards and recognitions for his outstanding work. He was an honouree for Georgia State's 40 Under 40 Class of 2024, Georgia State University.
MFCEM Dialogues #14
by
Prof. Krishna Rajarathnam,
Department of Biochemistry and Molecular Biology, Sealy Center for Structural Biology, The University of Texas, USA
on
Chemokine-neutrophil axis in health and disease: insights from structural biology and animal models
1 April 2025
Prof. Krishna Rajarathnam majored in Chemistry from IIT Madras followed by his Ph.D. in Chemistry from the University of California, Davis in the USA. After his post-doctoral research at the University of Alberta, he joined the University of Texas as a faculty member. Prof. Rajarathnam is an accomplished researcher with more than two decades of experience in the field of structural biology and biophysics. His laboratory is primarily interested in understanding the molecular mechanisms by which chemokines activate GPCR receptors and bind sulphated glycosaminoglycans (GAGs) to orchestrate in-vivo leukocyte recruitment to the infected tissue and activate leukocytes for microbial killing at the target site.
MFCEM Dialogues #13
by
Dr. Anil Koul,
VP & Head, Global Public Health discovery J&J
on
Title: Discovery of Bedaquiline and Its Impact on the Global TB Landscape
21 February 2025
MFCEM Dialogues & Prof. Arabindo Nath Bose Endowed Lecture by Dr. Anil Koul, VP & Head, Global Public Health discovery, J&J & a member of the Board of Directors of Janssen Pharmaceuticals. Dr. Koul also serves as a Professor of Translational Discovery at the London School of Hygiene and Tropical Medicine and has previously served as Director of the CSIR-Institute of Microbial Technology, Chandigarh.
MFCEM Dialogues #12
by
Dr. Umrao Monani,
De Vivo Professor of Neurology, Columbia University Medical Center
on
Title of the talk: : Mechanisms underlying infantile-onset spinal muscular atrophy: Clues from a novel disease modifier.
20th August 2024
Dr. Umrao Monani is the De Vivo Professor of Neurology at the Columbia University Medical Center and is the Director of the Colleen Giblin Research Laboratory at the medical centre.
The Bhupat & Jyoti Mehta Family Foundation
MFCEM at the Indian Institute of Technology Kanpur is generously supported by the Mehta Family Foundation.